Stelzer Laurie — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Stelzer Laurie has filed 4 SEC Form 4 filings across 4 companies in the last 90 days.

Profile

Laurie Stelzer is listed as an insider for MBX Biosciences, Inc. (CIK 0001644348) in the company's SEC Form 4 filing dated 2026-01-22. The filing shows no reported purchases or sales and does not disclose her specific role within MBX Biosciences. MBX Biosciences is a clinical-stage biopharma focused on Precision Endocrine Peptides (PEP) for endocrine and metabolic disorders.

Board memberships

• MBX Biosciences, Inc.

Awards & honors

• Named as an insider in MBX Biosciences' SEC filing (CIK 0001644348) dated 2026-01-22
• MBX Biosciences operates a PEP platform targeting endocrine and metabolic diseases

Companies — Last 90 Days

• Sionna Therapeutics, Inc. (SION) — 1 filings, last 2026-06-18
• PMV Pharmaceuticals, Inc. (PMVP) — 1 filings, last 2026-06-05
• MBX Biosciences, Inc. (MBX) — 1 filings, last 2026-06-05
• Spyre Therapeutics, Inc. (SYRE) — 1 filings, last 2026-05-29

Frequently Asked Questions

Who is Stelzer Laurie?

Laurie Stelzer is listed as an insider for MBX Biosciences, Inc. (CIK 0001644348) in the company's SEC Form 4 filing dated 2026-01-22. The filing shows no reported purchases or sales and does not disclose her specific role within MBX Biosciences. MBX Biosciences is a clinical-stage biopharma focused on Precision Endocrine Peptides (PEP) for endocrine and metabolic disorders.…

How many SEC Form 4 filings has Stelzer Laurie submitted recently?

4 primary Form 4 filings in the last 90 days, covering 4 companies.

Where can I see all of Stelzer Laurie's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week